The U.S. Food and Drug Administration has approved a highly effective HIV prevention drug that outperforms oral medications in stopping HIV transmission. Developed by Gilead Sciences, the drug ...
Lenacapavir, injectable HIV prevention drug, has been found to provide 100 percent protection against HIV infection among pregnant and breastfeeding women using it as pre-exposure prophylaxis ...
Experts have urged those who already received their first injection of the twice-yearly HIV preventing drug Lenacapavir to consider using combination prevention options, warning that the game changer ...
Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...
A Gilead Sciences drug that protects against HIV infection has won a highly anticipated FDA approval, becoming the first medication for HIV prevention available as a twice-yearly injection. The ...